Recruitment

Recruitment Status
Not yet recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Blood Pressure
  • Hypertension
Type
Interventional
Phase
Early Phase 1
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Comparisons of outcome variables will be made using a mixed model ANOVA.Masking: Triple (Participant, Care Provider, Investigator)Masking Description: Randomized, double-blinded, parallel-design approach study.Primary Purpose: Other

Participation Requirements

Age
Between 18 years and 79 years
Gender
Both males and females

Description

Hypertension, obesity, and insulin resistance are associated with elevated muscle sympathetic nerve activity (MSNA), which is important for blood pressure regulation. The measurement of MSNA is safely performed in humans using the microneurographic technique that involves recording sympathetic nerve...

Hypertension, obesity, and insulin resistance are associated with elevated muscle sympathetic nerve activity (MSNA), which is important for blood pressure regulation. The measurement of MSNA is safely performed in humans using the microneurographic technique that involves recording sympathetic nerve activity projecting to skeletal muscle using a small microelectrode at the peroneal nerve near the knee. The health of your blood vessels will be tested in this study, in addition to the activity of the nerves that control the blood vessels. The function of the nerves and blood vessels can be diminished by high blood glucose and lipids, and we will test the ability of a well-known antioxidant, ascorbic acid (vitamin C), to restore the function of the nerves and blood vessels.

Tracking Information

NCT #
NCT04832009
Collaborators
Not Provided
Investigators
Principal Investigator: Seth W. W Holwerda, PhD University of Kansas Medical Center